[go: up one dir, main page]

WO2020113485A1 - Capsule for regulating intestinal flora - Google Patents

Capsule for regulating intestinal flora Download PDF

Info

Publication number
WO2020113485A1
WO2020113485A1 PCT/CN2018/119459 CN2018119459W WO2020113485A1 WO 2020113485 A1 WO2020113485 A1 WO 2020113485A1 CN 2018119459 W CN2018119459 W CN 2018119459W WO 2020113485 A1 WO2020113485 A1 WO 2020113485A1
Authority
WO
WIPO (PCT)
Prior art keywords
copies
servings
capsule
intestinal flora
regulating intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2018/119459
Other languages
French (fr)
Chinese (zh)
Inventor
陈惠�
郑惠华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Original Assignee
JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd filed Critical JIANGSU ANHUI BIO-TECHNOLOGY Co Ltd
Priority to PCT/CN2018/119459 priority Critical patent/WO2020113485A1/en
Publication of WO2020113485A1 publication Critical patent/WO2020113485A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Definitions

  • the invention relates to a health food.
  • the object of the present invention is to provide a capsule for regulating intestinal flora.
  • a capsule for regulating intestinal flora characterized by being composed of the following parts by weight of raw materials:
  • the capsule for regulating intestinal flora is composed of the following parts by weight of raw materials:
  • the invention is rich in nutrients, has a variety of health-care nutrients, has excellent effects of regulating intestinal flora and maintaining intestinal function health, and is convenient to manufacture.
  • a capsule for regulating intestinal flora which is composed of the following parts by weight of raw materials:
  • a capsule for regulating intestinal flora which is composed of the following parts by weight of raw materials:
  • Bifidobacterium longum 10-20 copies (eg 10 copies, 15 copies, 20 copies)
  • Lactobacillus acidophilus 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Streptococcus thermophilus 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Bovine colostrum 10-20 copies (eg 10 copies, 15 copies, 20 copies)
  • Isomaltooligosaccharides 10-20 servings eg 10 servings, 15 servings, 20 servings.
  • Casein 10-20 copies eg 10 copies, 15 copies, 20 copies.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

A capsule for regulating intestinal flora, consisting of bifidobacterium longum, lactobacillus acidophilus, streptococcus thermophiles, bovine colostrum, isomaltooligosaccharide, and casein. The capsule is rich in nutrition, has a variety of healthcare nutrition ingredients, has excellent effects on regulating intestinal flora and maintaining intestinal function health, and is convenient to produce.

Description

调节肠道菌群的胶囊Capsule for regulating intestinal flora 技术领域Technical field

本发明涉及一种保健食品。The invention relates to a health food.

背景技术Background technique

一些人群存在肠道菌群混乱、肠道功能差等现象，现有的保健品等这种现象的效果不理想。Some people have the phenomenon of intestinal flora confusion and poor intestinal function. The effect of existing health products and other phenomena is not ideal.

技术问题technical problem

本发明的目的在于提供一种调节肠道菌群的胶囊。The object of the present invention is to provide a capsule for regulating intestinal flora.

技术解决方案Technical solution

一种调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：A capsule for regulating intestinal flora, characterized by being composed of the following parts by weight of raw materials:

长双歧杆菌          10-20份Bifidobacterium longum 10-20 copies

嗜酸乳杆菌          10-20份Lactobacillus acidophilus 10-20 servings

嗜热链球菌          10-20份Streptococcus thermophilus 10-20 servings

牛初乳              10-20份Bovine colostrum 10-20 copies

低聚异麦芽糖        10-20份Isomaltooligosaccharide 10-20 servings

酪蛋白              10-20份。Casein 10-20 servings.

所述的调节肠道菌群的胶囊，由下列重量份的原料混合组成：The capsule for regulating intestinal flora is composed of the following parts by weight of raw materials:

长双歧杆菌          13份Bifidobacterium longum 13 copies

嗜酸乳杆菌          15份Lactobacillus acidophilus 15 servings

嗜热链球菌          18份Streptococcus thermophilus 18 copies

牛初乳              11份Bovine colostrum 11 copies

低聚异麦芽糖        20份Isomaltooligosaccharide 20 servings

酪蛋白              16份。Casein 16 copies.

有益效果Beneficial effect

本发明营养丰富，具有多种保健营养成分，具有优异的调节肠道菌群、保持肠道功能健康的效果，制作方便。The invention is rich in nutrients, has a variety of health-care nutrients, has excellent effects of regulating intestinal flora and maintaining intestinal function health, and is convenient to manufacture.

本发明的最佳实施方式Best Mode of the Invention

实施例1：Example 1:

一种调节肠道菌群的胶囊，由下列重量份的原料混合组成：A capsule for regulating intestinal flora, which is composed of the following parts by weight of raw materials:

长双歧杆菌          13份Bifidobacterium longum 13 copies

嗜酸乳杆菌          15份Lactobacillus acidophilus 15 servings

嗜热链球菌          18份Streptococcus thermophilus 18 copies

牛初乳              11份Bovine colostrum 11 copies

低聚异麦芽糖        20份Isomaltooligosaccharide 20 servings

酪蛋白              16份。Casein 16 copies.

实施例2：Example 2:

一种调节肠道菌群的胶囊，由下列重量份的原料混合组成：A capsule for regulating intestinal flora, which is composed of the following parts by weight of raw materials:

长双歧杆菌          10-20份（例10份、15份、20份）Bifidobacterium longum 10-20 copies (eg 10 copies, 15 copies, 20 copies)

嗜酸乳杆菌          10-20份（例10份、15份、20份）Lactobacillus acidophilus 10-20 servings (eg 10 servings, 15 servings, 20 servings)

嗜热链球菌          10-20份（例10份、15份、20份）Streptococcus thermophilus 10-20 servings (eg 10 servings, 15 servings, 20 servings)

牛初乳              10-20份（例10份、15份、20份）Bovine colostrum 10-20 copies (eg 10 copies, 15 copies, 20 copies)

低聚异麦芽糖        10-20份（例10份、15份、20份）Isomaltooligosaccharides 10-20 servings (eg 10 servings, 15 servings, 20 servings)

酪蛋白              10-20份（例10份、15份、20份）。Casein 10-20 copies (eg 10 copies, 15 copies, 20 copies).

Claims (2)

一种调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：A capsule for regulating intestinal flora, characterized by being composed of the following parts by weight of raw materials: 长双歧杆菌          10-20份Bifidobacterium longum 10-20 copies 嗜酸乳杆菌          10-20份Lactobacillus acidophilus 10-20 copies 嗜热链球菌          10-20份Streptococcus thermophilus 10-20 copies 牛初乳              10-20份Bovine colostrum 10-20 copies 低聚异麦芽糖        10-20份Isomaltooligosaccharides 10-20 copies 酪蛋白              10-20份。Casein 10-20 servings. 根据权利要求1所述的调节肠道菌群的胶囊，其特征是：由下列重量份的原料混合组成：The capsule for regulating intestinal flora according to claim 1, characterized in that it is composed of the following parts by weight of raw materials: 长双歧杆菌          13份Bifidobacterium longum 13 copies 嗜酸乳杆菌          15份Lactobacillus acidophilus 15 servings 嗜热链球菌          18份Streptococcus thermophilus 18 servings 牛初乳              11份Bovine colostrum 11 copies 低聚异麦芽糖        20份Isomaltooligosaccharides 20 servings 酪蛋白              16份。Casein 16 copies.
PCT/CN2018/119459 2018-12-06 2018-12-06 Capsule for regulating intestinal flora Ceased WO2020113485A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/119459 WO2020113485A1 (en) 2018-12-06 2018-12-06 Capsule for regulating intestinal flora

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/119459 WO2020113485A1 (en) 2018-12-06 2018-12-06 Capsule for regulating intestinal flora

Publications (1)

Publication Number Publication Date
WO2020113485A1 true WO2020113485A1 (en) 2020-06-11

Family

ID=70975218

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/119459 Ceased WO2020113485A1 (en) 2018-12-06 2018-12-06 Capsule for regulating intestinal flora

Country Status (1)

Country Link
WO (1) WO2020113485A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112568344A (en) * 2020-12-10 2021-03-30 入圣生物科技无锡有限公司 Food capable of regulating intestinal tract and enhancing immunity and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031345A (en) * 2005-07-27 2007-02-08 Seiko:Kk Food composition having intestinal environment improving action
CN101199299A (en) * 2007-11-09 2008-06-18 湖南光大牧业科技有限公司 Lactobacillus milk beverage containing conjugated linoleic acid and preparation method thereof
CN101366734A (en) * 2008-06-18 2009-02-18 辽宁大生药业有限公司 Synbiotics medicament composition
WO2009147157A1 (en) * 2008-06-05 2009-12-10 Dsm Ip Assets B.V. Instant yoghurt
CN102742659A (en) * 2012-07-10 2012-10-24 陕西农产品加工技术研究院 Probiotic goat milk tablet and preparation method of probiotic goat milk tablet
CN103648510A (en) * 2009-05-11 2014-03-19 雀巢产品技术援助有限公司 Oral nutritional supplement comprising probiotics
CN107050062A (en) * 2016-11-08 2017-08-18 江西益盟科技有限公司 Treat lactic bacteria composition of constipation and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007031345A (en) * 2005-07-27 2007-02-08 Seiko:Kk Food composition having intestinal environment improving action
CN101199299A (en) * 2007-11-09 2008-06-18 湖南光大牧业科技有限公司 Lactobacillus milk beverage containing conjugated linoleic acid and preparation method thereof
WO2009147157A1 (en) * 2008-06-05 2009-12-10 Dsm Ip Assets B.V. Instant yoghurt
CN101366734A (en) * 2008-06-18 2009-02-18 辽宁大生药业有限公司 Synbiotics medicament composition
CN103648510A (en) * 2009-05-11 2014-03-19 雀巢产品技术援助有限公司 Oral nutritional supplement comprising probiotics
CN102742659A (en) * 2012-07-10 2012-10-24 陕西农产品加工技术研究院 Probiotic goat milk tablet and preparation method of probiotic goat milk tablet
CN107050062A (en) * 2016-11-08 2017-08-18 江西益盟科技有限公司 Treat lactic bacteria composition of constipation and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DU, YAJUN: "Growth-Prompoting Effect on Soluble Dietary Fibre to Intestinal Probiotics", CHINA DAIRY INDUSTRY, vol. 43, no. 7, 31 December 2015 (2015-12-31), pages 26 - 29, DOI: 20190820195820Y *
HE, SONG ET AL.: "Meta Analysis of Bifid-Preparations in Prevention of Secondary Diarrhea in Infants in China", CHINESE JOURNAL OF MICROECOLOGY, vol. 21, no. 8, 31 December 2009 (2009-12-31), pages 692 - 695, DOI: 20190820191117Y *
YANG, YANG ET AL.: "Probiotics Advantage Bacterium and the Best Ratio of the Probiotic Bacterias", FOOD SCIENCE AND TECHNOLOGY, vol. 38, no. 12, 31 December 2013 (2013-12-31), pages 19 - 22, DOI: 20190820190950Y *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112568344A (en) * 2020-12-10 2021-03-30 入圣生物科技无锡有限公司 Food capable of regulating intestinal tract and enhancing immunity and preparation method thereof

Similar Documents

Publication Publication Date Title
Gorreja et al. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies
Turpin et al. Lactobacillaceae and cell adhesion: genomic and functional screening
MY203053A (en) Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
Patrignani et al. Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections
Prajapati et al. Advances in probiotics research: mechanisms of action, health benefits, and limitations in applications
MX2022000369A (en) Bifidobacterium bifidum bacterial strain, the compositions thereof and related uses.
SI1565547T2 (en) Probiotic strains, a process for the selection of them, compositions thereof, and their use
PH12018502406A1 (en) Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
NO20033283D0 (en) Combination of probiotics
MY207753A (en) Composition for maintenance and/or improvement of memory/learning ability, and food, medicine and feed each containing said composition
CN111084386A (en) Probiotic supplement with function of improving intestinal tract
WO2020113485A1 (en) Capsule for regulating intestinal flora
MX2017012376A (en) Fermented flour nutraceutical tortilla and process for preparation thereof.
CN111388510A (en) Probiotic composition
JP2020513780A5 (en)
RU2018124842A (en) APPLICATION OF STARCH FOR IMPROVING THE QUALITY OF PREPARATION OF DRAINED FERMENTED DAIRY PRODUCT
MX2025012912A (en) Nutritional composition
WO2020113495A1 (en) Soft ganoderma lucidum spore oil capsule
Zirker Probiotic use in chronic kidney disease patients
Solomon New aspects of the production of fergated dairy products with probiotic properties
Kabiri et al. Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study.
JP2019170245A (en) Composition containing powdered milk derived from goat milk and bifidobacterium and/or lactic acid bacteria
Qian et al. Alterations in the gut microbiota of toddlers with cow milk protein allergy treated with a partially hydrolyzed formula containing synbiotics: A nonrandomized controlled interventional study
CN107874262A (en) A kind of compound lactobacillus polypeptide powder
Steyn A matter of the gut

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18942321

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18942321

Country of ref document: EP

Kind code of ref document: A1